Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Aadi Bioscience, Inc (AADI)  
$1.87 0.06 (3.11%) as of 4:30 Mon 6/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 46,780,000
Market Cap: 87.48(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.32 - $3.73
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Aadi Bioscience is a biopharmaceutical company focused on developing and commercializing precision therapies targeted to rare mutation-driven diseases. Co.'s primary drug product, FYARRO, is nab-sirolimus (sirolimus protein-bound particles for injectable suspension (albumin-bound)) for diseases driven by the mTOR pathway activation through mutations or deletions of specific genes such as Tuberous Sclerosis Complex 1 and 2. FYARRO is licensed to Co. by Abraxis BioScience, LLC, a wholly owned subsidiary of Bristol Myers Squibb Company, for various therapeutic areas including oncology, cardiovascular, and metabolic related diseases.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 10,643 140,332 638,332
Total Sell Value $0 $25,011 $226,696 $2,016,128
Total People Sold 0 3 4 4
Total Sell Transactions 0 3 10 35
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 159
  Page 1 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Dalal Anupam   –       •      –    2025-03-04 4 A $2.40 $3,746,400 I/I 1,561,000 3,410,402     -
   Zhao Baiteng   –       •      –    2025-03-04 4 A $2.40 $3,000,000 I/I 1,250,000 1,250,000     -
   Castelein Caley   –       •      –    2025-03-04 4 A $2.40 $3,998,400 I/I 1,666,000 2,165,998     -
   Ball Bryan See remarks   •       –      –    2025-03-04 4 A $2.40 $240,000 D/D 100,000 202,853     -
   Ball Bryan See remarks   •       –      –    2025-03-03 4 S $2.35 $5,045 D/D (2,147) 102,853 16%     
   Giacobello Scott M. CHIEF FINANCIAL OFFICER   •       –      –    2025-03-03 4 S $2.35 $6,594 D/D (2,806) 23,944 16%     
   Lennon David James CHIEF EXECUTIVE OFFICER   •       •      –    2025-03-03 4 S $2.35 $13,372 D/D (5,690) 33,429 16%     
   Ball Bryan See remarks   •       –      –    2025-03-01 4 OE $0.00 $0 D/D 5,000 105,000     -
   Giacobello Scott M. CHIEF FINANCIAL OFFICER   •       –      –    2025-03-01 4 OE $0.00 $0 D/D 6,750 26,750     -
   Lennon David James CHIEF EXECUTIVE OFFICER   •       •      –    2025-03-01 4 OE $0.00 $0 D/D 16,250 39,119     -
   Lennon David James CHIEF EXECUTIVE OFFICER   •       •      –    2024-10-03 4 S $1.94 $18,797 D/D (9,689) 22,869 -36%     
   Lennon David James CHIEF EXECUTIVE OFFICER   •       •      –    2024-10-02 4 OE $0.00 $0 D/D 32,558 32,558     -
   Desai Neil EXECUTIVE CHAIRMAN   •       •      –    2024-09-03 4 AS $1.71 $68,316 I/I (40,000) 1,171,543 67%     
   Desai Neil EXECUTIVE CHAIRMAN   •       •      –    2024-08-05 4 AS $1.34 $7,595 I/I (5,652) 1,211,543 75%     
   Desai Neil EXECUTIVE CHAIRMAN   •       •      –    2024-08-02 4 AS $1.41 $26,705 I/I (18,933) 1,217,195 73%     
   Desai Neil EXECUTIVE CHAIRMAN   •       •      –    2024-08-01 4 AS $1.50 $23,055 I/I (15,415) 1,236,128 57%     
   Desai Neil EXECUTIVE CHAIRMAN   •       •      –    2024-07-02 4 AS $1.34 $11,612 I/I (8,652) 1,251,543 61%     
   Desai Neil EXECUTIVE CHAIRMAN   •       •      –    2024-07-01 4 AS $1.45 $45,605 I/I (31,348) 1,260,195 48%     
   Desai Neil EXECUTIVE CHAIRMAN   •       •      –    2024-06-04 4 AS $1.77 $35,746 I/I (20,225) 1,291,543 22%     
   Desai Neil EXECUTIVE CHAIRMAN   •       •      –    2024-06-03 4 AS $1.81 $35,765 I/I (19,775) 1,311,768 13%     
   Desai Neil EXECUTIVE CHAIRMAN   •       •      –    2024-05-01 4 AS $1.93 $77,184 I/I (40,000) 1,331,543 -5%     
   Ball Bryan See remarks   •       –      –    2024-04-23 3 IO $0.00 $0 D/D 0 100,000 -2%     
   Desai Neil EXECUTIVE CHAIRMAN   •       •      –    2024-04-02 4 AS $2.23 $49,513 I/I (22,228) 1,371,543 -36%     
   Desai Neil EXECUTIVE CHAIRMAN   •       •      –    2024-04-01 4 AS $2.31 $41,101 I/I (17,772) 1,393,771 -40%     
   Desai Neil EXECUTIVE CHAIRMAN   •       •      –    2024-03-04 4 AS $2.10 $31,415 I/I (14,964) 1,411,543 -39%     

  159 Records found
  1  2  3  4  5  6  7   
  Page 1 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed